J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.
As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.